Key Record Dates Identifier: NCT04524611
Brief Title: Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)

First Submitted : August 20, 2020
First Submitted that Met QC Criteria : August 20, 2020
First Posted : August 24, 2020

Last Update Submitted that Met QC Criteria : June 11, 2021
Last Update Posted : June 14, 2021